Cite Filings / OBX
Feed Companies Filings Check
Sign in

CIK 0002130606

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Obsidian Therapeutics, Inc.

Sign in to watch
Ticker
OBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
421977778
Phone
+1 781-806-6245
Business address
1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138
Former names
Gazelle Parent, Inc.
Filings Financials Insiders Search text
All 44 Financials 5 Executive Compensation 3 Insider Trading 19 Beneficial Ownership Interest 6 Business Combinations 8 Public Offerings 3 Others 6
›
Filed in
  1. No filings match these filters. Clear filters
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership 2026-11-16
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-10-05
  4. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-11
  5. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-10
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-10
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership 2026-08-10

Page 1 of 1 · 6 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…